OncoBriefs - Oncology Research News

I have a confession: a lot of us have been treating cancer-cell “trash disposal” like boring housekeeping, when it may actually be one of the tumor’s more dramatic survival tricks.

High-grade serous ovarian cancer is one of oncology's tougher villains. It often spreads through the abdomen, settles into fluid called ascites, and builds a tumor neighborhood that is less "welcoming community garden" and more "sketchy alley with bad lighting and suspicious management."

The moment the survival curves split and stayed split, the researchers had a problem with the usual story: these gastric tumors looked epithelial enough to pass inspection, yet clinically they behaved like they had already kicked over the furniture. In this new British Journal of Cancer study, the...

If glofitamab were applying for a job, the hiring manager would slide across the table a truly ridiculous posting: must hunt lymphoma inside the brain, slip past the blood-brain barrier, wake up tired T cells, and try not to set off too much immune chaos on the way in. Most applicants would stare...

A lactate molecule leaves a sugar-burning cancer cell like a road-weary saxophonist stepping off a late train: not exactly glamorous, carrying too much baggage, but somehow about to change the whole room.

Palliative care has one of the worst branding problems in medicine. People hear the phrase and assume somebody has quietly dimmed the lights and started speaking in a sorrowful whisper. But palliative care is really about symptom control, practical support, planning, and helping people live as well...

For half a century, cancer researchers have had a recurring problem: we keep learning more about cells by removing them from the very neighborhoods that explain their behavior. It is a little like interviewing every guest after a dinner party, but only after blindfolding them, putting them in...

Tuberculosis has been treatable for decades, which sounds tidy until you learn the standard drug-susceptible TB regimen has long taken at least 6 months. Six. Months. For an infection caused by one bacterium. A bacterium, to be fair, that behaves like it read the employee handbook and found every...

Rip out the load-bearing wall during a home renovation and you do not get an "open concept" - you get a very expensive lesson in structural biology. That, more or less, is what this new breast cancer paper found: some hormone receptor-positive, HER2-negative breast cancers seem to delete or damage...

If ctDNA had social media, its first post would be: "Still here after treatment. Not great news. Please stop ignoring my red flags."

You probably checked a delivery status today, because modern life is apparently 40% waiting for tiny trucks on a map. Cancer researchers have their own version of that problem: how do you deliver something powerful to the right address without wrecking the whole neighborhood?

Your blood and immune cells usually train like a decent gym class - build, recover, repeat - and then acute myeloid leukemia shows up like a maniac doing deadlifts in the fire exit while everyone else gets shoved off the equipment.

Cancer behaves like the sort of scheming operator who rents a room, cuts the lights, jams the door, and then acts offended when security fails to show up. Immune checkpoint drugs are supposed to fix that by taking the brakes off your T cells, but the awkward truth is that many tumors still manage...

[Lights up on a cancer cell membrane, where a tiny drug-loaded antibody stands at the front door with a clipboard, a badge, and absolutely no idea the building has disabled the elevator.]

The study, published on April 28, 2026 in the British Journal of Cancer, zooms in on colorectal cancer and oxidative phosphorylation, usually shortened to OXPHOS because scientists also enjoy making things sound like IKEA furniture [1]. OXPHOS is the process mitochondria use to make ATP, the...

Cancer, ever the melodramatic space tyrant, does not simply sit there waiting to be vaporized by the immune system. It builds a fortress, scrambles the radio signals, bribes the guards, and then has the nerve to call it "immune evasion."

"8,900" is not a statistic so much as a lot of extra operating lists, extra coffee, and a few NHS schedulers staring into the middle distance. That is the modeled annual increase in cancer resections if England eventually adds a multi-cancer early detection, or MCED, blood test program for people...

Take one scarred lung, add years of survivorship, sprinkle in invisible dust from the air, and hope the recipe does not produce a second tumor - because apparently cancer was not satisfied with one appearance and wanted a franchise deal.

Review for EGFR signaling in colon cancer: 1 star. Extremely clingy, obsessed with growth, ignores boundaries, and keeps inviting metastasis to every gathering. Scientists have spent years trying to break up that toxic relationship, and this new study tests a very practical question: can we keep...

Customer review, posted by a pancreatic tumor: "Five stars for Fra-2. Showed up whenever KRAS got blocked, rewired the whole office, kept growth signals humming, no notes." Which is funny right up until you remember the office in question is pancreatic ductal adenocarcinoma, a cancer with the...